Part,  Chapter, Paragraph

 1   II,     5.  5.  1|        National Comorbidity Survey. Br J Psychiatry 168(Suppl.
 2   II,     5.  5.  1|        World Mental Health Surveys. Br J Psychiatry 192(5):368-
 3   II,     5.  5.  3|        treatment for schizophrenia. Br J Psychiatry 183:427-435.~
 4   II,     5.  5.  3|     schizophrenia, A meta-analysis. Br J Psychiatry 171:502-8.~
 5   II,     5.  5.  3| international survey and comparison Br J Psychiatry 187: 248-255.~
 6   II,     5.  5.  3|      European guidelines institute. Br J Psychiatry 188:193.~Lindström
 7   II,     5.  5.  3|     receiving depot antipsychotics. Br J Psychiatry 153:214-7.~
 8   II,     5.  5.  3|             as greater flexibility. Br Med J 331:60-61.~Beilmann
 9   II,     5.  5.  3|         disorders. A meta-analysis. Br J Psychiatry 170:205-228.~
10   II,     5.  5.  3|             in Parkinson’s disease. Br J Clin Pract 49(6):288-293.~
11   II,     5.  5.  3|         disease in a Scottish city. Br Med J 292(6519):534-536.~
12   II,     5.  8.  7|            2006; 3: 233-242~ ~Celli BR, MacNee W (2006): ATS/ERS
13   II,     5.  8.  7|        smokers aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-
14   II,     5. 11.  7|             for population surveys. Br J Dermatol 2003;149:794-
15   II,     5. 11.  7|        epidemiology of skin cancer. Br J Dermatol 2002;146(S61):
16   II,     5. 11.  7|          hospital-based assessment. Br J Dermatol 1994;131(S44):
17   II,     5. 11.  7|          possible ethnic variation. Br J Dermatol 1995;132:772-
18   II,     5. 11.  7|          Disability in Dermatology. Br J Hosp Med 1991;46:336.~ ~
19   II,     5. 11.  7|            EDEN hand-eczema survey. Br J Dermatol 2004;151(2):446-
20   II,     5. 11.  7|           international comparison. Br J Dermatol 2002;147:716-
21   II,     5. 11.  7|           onychomycosis in Britain. Br J Dermatol 1993;129:101-
22   II,     5. 11.  7|          disease of the advantaged? Br Med J 1994;308:1132-35.~ ~
23   II,     5. 11.  7|     Criteria for atopic dermatitis. Br J Dermatol (1994b):131:383-
24   II,     5. 15.  6|          orphan medicinal products. Br J Clin Pharmacol 2006, 62:
25   II,     9.  1.  1|             the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
26   II,     9.  3.  2|             the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
27  III,    10.  2.  1|             United Kingdom in 2003. Br Dent J. 2006; 200: 487-491.~ ~
28  III,    10.  2.  5|            a national birth cohort. Br J Psychiatry 2004;184:28-
29  III,    10.  6.  1|         health and physical health. Br J Med Psychol 61(1):17-36.~ ~
30   IV,    11.  6.  5|              79-80.~ ~Mainz J, Krog BR et al. (2004): "Nationwide